Formpipe (Q3 Review) - Lasernet is taking form in better shape than assumed

Redeye strengthens its positive view of Formpipe following the Q3 report, showing a rebound in ACV and encouraging cost control.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/